DexCom's growth rate has been improving, but that hasn't been enough of a reason for investors to buy up the stock.

Dexcom has announced that the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over the age of 18 with diabetes will launch in the United States on Dec. 1.

Sands Capital, an investment management company, released its “Sands Capital Select Growth Strategy” Q3 2025 investor letter. A copy of the letter can be downloaded here. U.S. large-cap growth ...

Dexcom’s “Smart Basal” has received FDA clearance for people with type 2 diabetes using long-acting insulin. The feature will ...

DexCom recently announced the upcoming U.S. launch of its G7 15 Day Continuous Glucose Monitoring system and received FDA clearance for its Smart Basal insulin dosing optimizer, both targeting ...

Analysts are intrested in these 5 stocks: ( ($NOW) ), ( ($DXCM) ), ( ($COIN) ), ( ($JMIA) ) and ( ($KEYS) ). Here is a breakdown of their recent ...

Dexcom announced the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes will ...

The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that securities class action lawsuits have been ...

NEW YORK, NY / ACCESS Newswire / November 27, 2025 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws ...

Labaton Keller Sucharow LLP ("Labaton") announces that, on November 25, 2025, it filed a securities class action lawsuit (the "Complaint") on behalf of its client Boston Retirement System ("Boston") ...

November is National Diabetes Month, and Durango's Bruce Moss is proving diabetes doesn’t have to slow you down. At 67, he ...

The bull case for DexCom is that the company continues to grow and has a lot of room to grow more. The bear case for the stock is that DexCom's sky-high valuation may be hard to justify in the long ...